TIM-BRIM-DOR-LAT- timolol - brimonidine - dorzolamide - latanoprost solution/ drops 
ImprimisRx NJ

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Store under refrigeration 2° to 8° C (36° to 46° F)

Bottle Label

Bottle LabelBottle Label

TIM-BRIM-DOR-LAT 
timolol - brimonidine - dorzolamide - latanoprost solution/ drops
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:70261-522
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DORZOLAMIDE HYDROCHLORIDE (UNII: QZO5366EW7) (DORZOLAMIDE - UNII:9JDX055TW1) DORZOLAMIDE20 mg  in 1 mL
BRIMONIDINE TARTRATE (UNII: 4S9CL2DY2H) (BRIMONIDINE - UNII:E6GNX3HHTE) BRIMONIDINE TARTRATE1.5 mg  in 1 mL
LATANOPROST (UNII: 6Z5B6HVF6O) (LATANOPROST - UNII:6Z5B6HVF6O) LATANOPROST0.05 mg  in 1 mL
TIMOLOL MALEATE (UNII: P8Y54F701R) (TIMOLOL ANHYDROUS - UNII:5JKY92S7BR) TIMOLOL ANHYDROUS5 mg  in 1 mL
Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70261-522-055 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product01/01/2018
Image of Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other01/01/2018
Labeler - ImprimisRx NJ (931390178)

Revised: 5/2018
Document Id: 6bb5e498-b278-191a-e053-2a91aa0acab3
Set id: 6ba4f0b3-d776-3485-e053-2991aa0abab3
Version: 3
Effective Time: 20180508
 
ImprimisRx NJ